Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts

Ruth R. Magaye, Feby Savira, Xin Xiong, Kevin Huynh, Peter J. Meikle, Christopher Reid, Bernard L. Flynn, David Kaye, Danny Liew, Bing H. Wang

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)


The sphingolipid de novo synthesis pathway, encompassing the sphingolipids, the enzymes and the cell membrane receptors, are being investigated for their role in diseases and as potential therapeutic targets. The intermediate sphingolipids such as dihydrosphingosine (dhSph) and sphingosine (Sph) have not been investigated due to them being thought of as precursors to other more active lipids such as ceramide (Cer) and sphingosine 1 phosphate (S1P). Here we investigated their effects in terms of collagen synthesis in primary rat neonatal cardiac fibroblasts (NCFs). Our results in NCFs showed that both dhSph and Sph did not induce collagen synthesis, whilst dhSph reduced collagen synthesis induced by transforming growth factor β (TGFβ). The mechanisms of these inhibitory effects were associated with the increased activation of the de novo synthesis pathway that led to increased dihydrosphingosine 1 phosphate (dhS1P). Subsequently, through a negative feedback mechanism that may involve substrate-enzyme receptor interactions, S1P receptor 1 expression (S1PR1) was reduced.

Original languageEnglish
Article number100837
Number of pages11
JournalIJC Heart & Vasculature
Publication statusPublished - Aug 2021


  • Cardiac fibroblasts
  • Collagen synthesis
  • Dihydrosphingosine
  • Sphingolipid
  • TGFβ

Cite this